Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

CTRV

Contravir Pharmaceuticals Inc (CTRV)

Contravir Pharmaceuticals (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CTRV
DatumZeitQuelleÜberschriftSymbolFirma
08/11/201912h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
07/11/201918h56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
23/10/201922h30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
21/10/201922h26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CTRVContravir Pharmaceuticals (MM)
16/10/201922h54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
10/10/201917h33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
08/10/201922h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
03/10/201922h21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
04/09/201917h47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
03/09/201922h40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
14/08/201923h30Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTRVContravir Pharmaceuticals (MM)
14/08/201915h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
07/08/201919h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
31/07/201919h42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
30/07/201922h50Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
29/07/201922h15GlobeNewswire Inc.Hepion Pharmaceuticals Receives FDA Authorization to Proceed with IND Opening Study of CRV431 for NASHNASDAQ:CTRVContravir Pharmaceuticals (MM)
25/07/201922h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
25/07/201922h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
25/07/201922h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
25/07/201922h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
25/07/201922h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
25/07/201922h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
25/07/201922h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
23/07/201914h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
22/07/201920h00GlobeNewswire Inc.ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA”NASDAQ:CTRVContravir Pharmaceuticals (MM)
28/06/201914h43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTRVContravir Pharmaceuticals (MM)
27/06/201915h54Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTRVContravir Pharmaceuticals (MM)
27/06/201914h00GlobeNewswire Inc.ContraVir Pharmaceuticals Submits IND Application for CRV431 for NASHNASDAQ:CTRVContravir Pharmaceuticals (MM)
20/06/201922h30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
20/06/201922h30GlobeNewswire Inc.ContraVir Pharmaceuticals Receives Positive FDA Response to CRV431 Pre-IND Package for NASHNASDAQ:CTRVContravir Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:CTRV

Kürzlich von Ihnen besucht

Delayed Upgrade Clock